Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Cadilla Challenges NPPA order clauses on Price Fixation of 847 formulations, DOP rejects plea

      Cadilla Challenges NPPA order clauses on Price Fixation of 847 formulations, DOP rejects plea

      Farhat Nasim27 Nov 2019 2:22 PM IST
      The footnote (b) stated, "In respect of any other scheduled formulation, for which ceiling price is not mentioned above, the manufacturers shall...
      3 Indian-origin healthcare startup executives charged in USD 1 billion fraud in US

      3 Indian-origin healthcare startup executives charged in USD 1 billion fraud in US

      Farhat Nasim27 Nov 2019 11:59 AM IST
      The co-founders of Outcome Health Rishi Shah, 33, and Shradha Aggarwal, 34, and former executive Ashik Desai, 26, are among six people accused of...
      Indoco Remedies CRO AnaCipher gets Establishment Inspection Report from USFDA

      Indoco Remedies CRO AnaCipher gets Establishment Inspection Report from USFDA

      Farhat Nasim26 Nov 2019 11:30 AM IST
      New Delhi: Drug firm Indoco Remedies Ltd. recently announced the receipt of Establishment Inspection Report (EIR) for its Clinical Research...
      CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality

      CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality

      Farhat Nasim25 Nov 2019 3:41 PM IST
      New Delhi: The nodal drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 36 drugs as not of standard...
      Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

      Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

      Farhat Nasim25 Nov 2019 12:00 PM IST
      The investment of Rs 130 crore includes a significant primary commitment which includes the merger of two Ujala Healthcare hospitals as well as the...
      Unichem Labs gets USFDA nod for generic version of Tenormin tablets

      Unichem Labs gets USFDA nod for generic version of Tenormin tablets

      Farhat Nasim25 Nov 2019 9:45 AM IST
      Unichem Labs said Atenolol tablets USP is a generic version of TENORMIN (Atenolol) Tablets, 25 mg, 50 mg, and 100 mg, of Alvogen Malta Operations...
      Lupin launches generic Potassium Chloride for oral solution USP post USFDA nod

      Lupin launches generic Potassium Chloride for oral solution USP post USFDA nod

      Farhat Nasim25 Nov 2019 9:15 AM IST
      Mumbai: Pharma major Lupin Limited (Lupin) recently announced the launch of Potassium Chloride (KCl) for Oral Solution USP, 20 mEq, having received an...
      NPPA fixes ceiling price of Zydus Cadila Tiotropium post DoP orders

      NPPA fixes ceiling price of Zydus Cadila Tiotropium post DoP orders

      Farhat Nasim24 Nov 2019 3:00 PM IST
      New Delhi: In an implementation of directions given in line with review orders issued by the Department of Pharmaceuticals (DOP), the apex drug price...
      FIRST: Lupin launches Adhero, smart device to support treatment of respiratory disease in India

      FIRST: Lupin launches Adhero, smart device to support treatment of respiratory disease in India

      Farhat Nasim24 Nov 2019 10:15 AM IST
      Mumbai: Pharma major Lupin Limited (Lupin) recently announced the launch of “ADHERO,” a new connected smart device for metered-dose inhalers. This...
      Pharmacist arrested for selling Tydol Tablets in bulk sans prescription

      Pharmacist arrested for selling Tydol Tablets in bulk sans prescription

      Farhat Nasim23 Nov 2019 3:21 PM IST
      During the investigation, it was revealed that the two deceased had an overdose of the drug (Tydol tablets) that they had taken for pleasure which led...
      Alembic Pharma gets USFDA nod for generic version of Jadenu, Exjade tablet to treat chronic iron overload

      Alembic Pharma gets USFDA nod for generic version of Jadenu, Exjade tablet to treat chronic iron overload

      Farhat Nasim23 Nov 2019 12:34 PM IST
      Deferasirox tablets are generic versions of Novartis Pharmaceuticals Corporation’s Jadenu tablets and Exjade tablets for oral suspension in the same...
      Govt still mulling to bring medical devices under CDSCO: Minister tells parliament

      Govt still mulling to bring medical devices under CDSCO: Minister tells parliament

      Farhat Nasim20 Nov 2019 2:36 PM IST
      New Delhi: The NITI Aayog has not rejected the proposal to bring medical devices under the Central Drugs Standard Control Organisation (CDSCO), the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok